Robert Chess, Director at Twist Bioscience Corp (TWST), sold 7,200 shares at $47.76 ($340K) on 2024-11-11, disclosed to the SEC on 2024-11-13.
Scheduled sale ($340k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.99 | 2,324 | $109K | 32.1% |
| 2 | $46.99 | 2,324 | $109K | 32.1% |
| 3 | $47.76 | 1,276 | $61K | 17.9% |
| 4 | $47.76 | 1,276 | $61K | 17.9% |
| Total | $47.26 avg | 7,200 | $340K | 100% |
| Filing → |
| TWST | SELL | 2026-02-18 | $105K | — | Filing → |
| TWST | SELL | 2025-02-11 | $312K | — | Filing → |
| TWST | SELL | 2025-01-10 | $250K | — | Filing → |